Country

Clinical trials in Croatia

Active obesity and GLP-1 studies with at least one location in Croatia.

9active studies

5recruiting now

27countries represented

121largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Diabetes Mellitus, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Argentina, Brazil74 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT07533175See eligibility →

Recruiting nowPhase 3

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Overweight, ObesityCondition

Cagrilintide, SemaglutideTreatment

Australia, Austria121 locations

Novo Nordisk A/SSponsor

Updated 2026-08-31 · NCT07253285See eligibility →

Recruiting nowPhase 2

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Diabetes Mellitus, Type 2Condition

NNC0662-0419, SemaglutideTreatment

Croatia, Hungary63 locations

Novo Nordisk A/SSponsor

Updated 2026-08-10 · NCT07415954See eligibility →

Recruiting nowNot applicable

Prognostic Value of SII and SIRI in Obesity-Related Metabolic Complications

Overweight and Obesity, InflammationCondition

Nutritional counsellingTreatment

Croatia1 locations

University of RijekaSponsor

Updated 2026-05-07 · NCT07431593See eligibility →

Recruiting nowNot applicable

Remission of Type 2 Diabetes With Lifestyle Intervention

Diabetes Mellitus Type 2, Obese DiabeticsCondition

Mediterranean diet, Physical activity interventionTreatment

Croatia1 locations

University of Split, School of MedicineSponsor

Updated 2025-06-12 · NCT07017127See eligibility →

Opening soonNot applicable

Impact of Lifestyle on Health Maintenance: A Randomized Controlled Trial

Metabolic Syndrome, Inactivity/Low Levels of ExerciseCondition

Intervention of physical activity, Mediterranean Diet EducationTreatment

Croatia1 locations

University of ZadarSponsor

Updated 2026-09-04 · NCT07314957See eligibility →

Opening soonPhase 3

AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Obesity, OverweightCondition

NNC0487-0111, SemaglutideTreatment

Argentina, Brazil120 locations

Novo Nordisk A/SSponsor

Updated 2026-03-12 · NCT07400107See eligibility →

Opening soonNot applicable

Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy

Obese Patients, Bariatric Surgical PainCondition

Levobupivacaine, Dexamethasone contained in the solution for thoracic paravertebral blockTreatment

Croatia1 locations

IVO JURISICSponsor

Updated 2025-07-24 · NCT07084753See eligibility →

Active, not recruitingPhase 3

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

Overweight, ObesityCondition

Cagrilintide, Placebo (matched to Cagrilintide)Treatment

Argentina, Canada67 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT07220759See eligibility →

Related countries

United States1,107 China326 Canada158 France110 Spain98 Germany95

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.